Physicians' Academy for Cardiovascular Education

Catheter ablation improves mortality and morbidity in patients with heart failure and atrial fibrillation

Catheter Ablation for Atrial Fibrillation with Heart Failure

Marrouche NF, Brachmann J, Andresen D, et al. - N Engl J Med 2018;378:417-27

Background

The treatment of atrial fibrillation (AF) improves long-term outcomes in patients with heart failure (HF), but the most beneficial treatment option is debated [1]. Catheter ablation is indicated for symptomatic, drug-resistant AF, and some data have shown that it is also associated with positive outcomes in HF patients [2-4].

In the Catheter Ablation versus Standard Conventional Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation (CASTLE-AF) trial, a multicenter, open-label, randomized, controlled trial, the effect of catheter ablation on morbidity and mortality was evaluated compared with medical therapy in HF patients with symptomatic AF.

The main inclusion criteria were: New York Heart Association (NYHA) class II-IV, left ventricular ejection fraction (LVEF) ≤ 35%, paroxysmal or persistent AF not responding to antiarrhythmic drugs, or with serious adverse events due to antiarrhythmic drug therapy, implantation of a Biotronik-manufactured cardioverter–defibrillator (ICD) device or a cardiac resynchronization therapy defibrillator (CRT-D) with automatic daily remote-monitoring capabilities. Patients were randomly assigned in a 1:1 ratio to receive catheter ablation or medical therapy for AF. Medical therapy for AF was administered based on medical guidelines. For all patients, the Biotronik Home Monitoring option was activated to monitor the recurrence of AF. If AF recurred, a repeat ablation was recommended unless contraindicated clinically.

The primary end point was a composite of all-cause death or HF worsening leading to an unplanned overnight hospitalization. Secondary end points included all-cause death, unplanned hospitalization due to HF, death from CVD, LVEF increase and achievement of sinus rhythm.

Main results

Conclusion

Catheter ablation is associated with a lower mortality and morbidity rate compared to medical therapy in patients with HF and AF. Moreover, catheter ablation improved the LVEF and reduced the burden of AF.

References

Show references

Download the slide Find this article online at N Engl J Med

Click here to view the slide